Dendrosomal curcumin nanoformulation downregulates pluripotency genes via miR-145 activation in U87MG glioblastoma cells
Open Access
- 1 January 2014
- journal article
- Published by Taylor & Francis Ltd in International Journal of Nanomedicine
- Vol. 9, 403-417
- https://doi.org/10.2147/ijn.s48136
Abstract
Peer reviewed article authored by (Tahmasebi Mirgani M, Isacchi B, Sadeghizadeh M, Marra F, Bilia AR, Mowla SJ, Najafi F, Babaei E). Read article or submit your manuscript for publishing.Keywords
This publication has 45 references indexed in Scilit:
- Glioblastoma cells: A heterogeneous and fatal tumor interacting with the parenchymaLife Sciences, 2011
- SOX2 expression and amplification in gliomas and glioma cell lines.2011
- Activation of Neural and Pluripotent Stem Cell Signatures Correlates with Increased Malignancy in Human GliomaPLOS ONE, 2011
- Regulation of Stem Cell Pluripotency and Differentiation Involves a Mutual Regulatory Circuit of the Nanog, OCT4, and SOX2 Pluripotency Transcription Factors With Polycomb Repressive Complexes and Stem Cell microRNAsStem Cells and Development, 2009
- Abate and Switch: miR-145 in Stem Cell DifferentiationCell, 2009
- MicroRNA-145 Regulates OCT4, SOX2, and KLF4 and Represses Pluripotency in Human Embryonic Stem CellsCell, 2009
- Oct4 is expressed in human gliomas and promotes colony formation in glioma cellsGlia, 2008
- Stem Cell Markers in GliomasNeurochemical Research, 2008
- Cancer stem cell biology: from leukemia to solid tumorsCurrent Opinion in Cell Biology, 2004
- Glioblastoma multiforme: The terminatorProceedings of the National Academy of Sciences of the United States of America, 2000